Search Results 1371-1380 of 17874 for Assay
... assays). Exclusion Criteria: Patients who are recipients of ABO incompatible kidney transplants. Patient with an eGFR ≤30 m/min at time of study entry ...
... assays). Group A: PD-L1 expression ≥ 1% <50%; Group B: PD-L1 expression ≥ 50%. Complete surgical resection of the primary NSCLC must be deemed achievable by ...
The secondary goal is to asses clinical endopoints associated with standard of care therapies for TCR MM, in a real-world setting during 12 months of ...
Your body stops producing enough new blood cells in this rare and serious condition, possibly causing fatigue, higher risk of infections and uncontrolled ...
These concussion screening and testing tools help measure brain function after head trauma and help athletes at risk of head injuries.
About this study. The CASCADE Familial Hypercholesterolemia Registry will track therapy, clinical outcomes, and patient-reported outcomes over time aiming ...
The BinaxNOW™ COVID-19 Ag Card is a useful tool for the rapid detection of SARS-CoV-2 and screening for COVID-19 in both symptomatic and asymptomatic patient ...
Learn about detection, diagnostic approaches, treatment options and advances for prostate cancer, including robotic prostatectomy and current research.
Hematology — Learn about innovative diagnosis and treatment options for blood diseases, including cancers, at Mayo Clinic.
All other subjects must have either the Mantoux (purified protein derivative [PPD]) tuberculin skin test or interferon gamma release assay (IGRA) performed.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!